FDA News

Latest News

AND017 Receives FDA Orphan Drug Designation for Sickle Cell Disease | Image Credit: US Food and Drug Administration
AND017 Receives FDA Orphan Drug Designation for Sickle Cell Disease

October 25th 2024

On October 25, 2024, Kind Pharmaceutical announced receipt of FDA Orphan Drug Designation for AND017 in the treatment of sickle cell disease.

FDA Issues CRL for Ketamine to Treat Pain, Mental Health, and More
FDA Issues CRL for Ketamine to Treat Pain, Mental Health, and More

October 23rd 2024

FDA Approves Sodium Oxybate for Cataplexy, Excessive Daytime Sleepiness in Pediatric Narcolepsy
FDA Approves Sodium Oxybate for Cataplexy, Excessive Daytime Sleepiness in Pediatric Narcolepsy

October 17th 2024

FDA black and white logo | Credit: US Food and Drug Administration
FDA Extends Review of Obeticholic Acid (Ocaliva) sNDA for Primary Biliary Cholangitis

October 17th 2024

FDA Clears Long-Term Laser Treatment for Inflammatory Acne Vulgaris
FDA Clears Long-Term Laser Treatment for Inflammatory Acne Vulgaris

October 15th 2024

<1
...
7891011
© 2024 MJH Life Sciences

All rights reserved.